Responses
Regular and young investigator award abstracts
Immune-stimulants and immune modulators
583 Novel, potent, and selective inhibitors of hypoxia-inducible factor (HIF)-2α reverse pro-tumorigenic transcriptional programming in cancer, stromal, and immune cells
Compose a Response to This Article
Other responses
No responses have been published for this article.
